Abstract
Epigenetics harbours all regulatory information that, beyond nucleotide sequences, allows cells to “make decisions” throughout their lifetime in response to the external environment. The information can be transitory or relatively stable, and is even transmittable either to daughter cells or to the next generations through the germ line. Recent discoveries shed light on numerous connections between metabolites and epigenetic chromatin-modifying enzymes, providing a link between the metabolic state of the cell and epigenetics, and ultimately between metabolism, gene expression and cell fate. In this review, we discuss the possible connections between metabolism and epigenetic regulation of stem cell differentiation and self-renewal. Moreover, we describe pertinent literature that could explain how altered metabolic state and nutrition can contribute to disease development through epigenetic modifications. A special section is dedicated to the emerging link between the circadian clock, metabolic transcriptional regulation by epigenetic mechanisms and their implication in stem cell homeostasis.
Keywords: Circadian rhythms, epigenetics, metabolism, microRNAs, nutrition, stem cells.
Current Stem Cell Research & Therapy
Title:Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Volume: 11 Issue: 4
Author(s): Daniele Avitabile, Alessandra Magenta, Andrea Lauri, Elisa Gambini, Gabriella Spaltro and Maria Cristina Vinci
Affiliation:
Keywords: Circadian rhythms, epigenetics, metabolism, microRNAs, nutrition, stem cells.
Abstract: Epigenetics harbours all regulatory information that, beyond nucleotide sequences, allows cells to “make decisions” throughout their lifetime in response to the external environment. The information can be transitory or relatively stable, and is even transmittable either to daughter cells or to the next generations through the germ line. Recent discoveries shed light on numerous connections between metabolites and epigenetic chromatin-modifying enzymes, providing a link between the metabolic state of the cell and epigenetics, and ultimately between metabolism, gene expression and cell fate. In this review, we discuss the possible connections between metabolism and epigenetic regulation of stem cell differentiation and self-renewal. Moreover, we describe pertinent literature that could explain how altered metabolic state and nutrition can contribute to disease development through epigenetic modifications. A special section is dedicated to the emerging link between the circadian clock, metabolic transcriptional regulation by epigenetic mechanisms and their implication in stem cell homeostasis.
Export Options
About this article
Cite this article as:
Avitabile Daniele, Magenta Alessandra, Lauri Andrea, Gambini Elisa, Spaltro Gabriella and Cristina Vinci Maria, Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation, Current Stem Cell Research & Therapy 2016; 11 (4) . https://dx.doi.org/10.2174/1574888X11666151203223839
DOI https://dx.doi.org/10.2174/1574888X11666151203223839 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteasome Inhibitors and Modulators of Angiogenesis in Multiple Myeloma
Current Medicinal Chemistry Long Chain n-3 Polyunsaturated Fatty Acids in the Prevention of Allergic and Cardiovascular Disease
Current Pharmaceutical Design Cannabis Phenolics and their Bioactivities
Current Medicinal Chemistry Anthraquinones: Analytical Techniques as a Novel Tool to Investigate on the Triggering of Biological Targets
Current Drug Targets Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy The Endocannabinoid System in Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches
Current Cancer Drug Targets Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry The Stable Isotope Use in the Exploration of Bioavailability and Metabolism of Magnesium
Current Nutrition & Food Science The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Current Medicinal Chemistry Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Current Cancer Drug Targets Interplay between Epigenetics & Cancer Metabolism
Current Pharmaceutical Design Genetic Manipulation of Human Embryonic Stem Cells: A System to Study Early Human Development and Potential Therapeutic Applications
Current Gene Therapy The Mutator Phenotype in Cancer: Molecular Mechanisms and Targeting Strategies
Current Drug Targets The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug Targets Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Current Protein & Peptide Science Disodium Phosphate of Novel Pyrazole-Linked Norcantharidin Analogs:Design, Synthesis and their Anticancer Evaluation
Letters in Drug Design & Discovery Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Management of Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Current Immunology Reviews (Discontinued)